Ran Frenkel, EVP, WW Development Operations at Karyopharm Therapeutics Inc. (KPTI), bought 3,000 shares at $29.43 ($95K) on 2015-04-06, disclosed to the SEC on 2015-04-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.43 | 1,000 | $29K | 30.8% |
| 2 | $33.00 | 2,000 | $66K | 69.2% |
| Total | $31.81 avg | 3,000 | $95K | 100% |
| Filing → |
| KPTI | SELL | 2022-02-09 | $20K | — | Filing → |
| KPTI | SELL | 2021-02-22 | $43K | — | Filing → |
| KPTI | SELL | 2021-02-17 | $32K | — | Filing → |